Colitis, Ulcerative

"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.

Descriptor ID	D003093
MeSH Number(s)	C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
Concept/Terms	Colitis, Ulcerative Colitis, Ulcerative Idiopathic Proctocolitis Ulcerative Colitis Colitis Gravis Inflammatory Bowel Disease, Ulcerative Colitis Type

Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".

Diseases [C]
Digestive System Diseases [C06]
Gastrointestinal Diseases [C06.405]
Gastroenteritis [C06.405.205]
Colitis [C06.405.205.265]
Colitis, Ulcerative [C06.405.205.265.231]
Inflammatory Bowel Diseases [C06.405.205.731]
Colitis, Ulcerative [C06.405.205.731.249]
Intestinal Diseases [C06.405.469]
Colonic Diseases [C06.405.469.158]
Colitis [C06.405.469.158.188]
Colitis, Ulcerative [C06.405.469.158.188.231]
Inflammatory Bowel Diseases [C06.405.469.432]
Colitis, Ulcerative [C06.405.469.432.249]

Below are MeSH descriptors whose meaning is related to "Colitis, Ulcerative".

Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.

Bar chart showing 71 publications over 21 distinct years, with a maximum of 9 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2002	1	0	1
2003	0	2	2
2004	0	1	1
2005	1	0	1
2009	3	0	3
2010	2	1	3
2011	4	0	4
2012	4	2	6
2013	1	0	1
2014	1	1	2
2015	4	0	4
2016	1	0	1
2017	2	1	3
2018	1	0	1
2019	3	0	3
2020	6	1	7
2021	5	3	8
2022	7	0	7
2023	3	0	3
2024	7	2	9

Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.

Li X, Duan W, Zhu Y, Ji R, Feng K, Kathuria Y, Xiao H, Yu Y, Cao Y. Transcriptomics and metabolomics reveal the alleviation effect of pectic polysaccharide on dextran sodium sulfate-induced colitis mice. Int J Biol Macromol. 2025 Feb; 288:138755.

View in: PubMed
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 10 03; 30(10):1776-1787.

View in: PubMed
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314.

View in: PubMed
Li X, Chen Y, Peng X, Zhu Y, Duan W, Ji R, Xiao H, Li X, Liu G, Yu Y, Cao Y. Anti-inflammation mechanisms of a homogeneous polysaccharide from Phyllanthus emblica L. on DSS induced colitis mice via the gut microbiota and metabolites alteration. Food Chem. 2024 Nov 30; 459:140346.

View in: PubMed
Gu Q, Jiang Z, Li K, Li Y, Yan X, McClements DJ, Ma C, Liu F. Effectiveness of probiotic- and fish oil-loaded water-in-oil-in-water (W1/O/W2) emulsions at alleviating ulcerative colitis. Food Funct. 2024 Jun 04; 15(11):5797-5812.

View in: PubMed
Ghodasara SK, Hauser KM, Oldewurtel KM, Rolandelli RH, Nemeth ZH. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease. Am Surg. 2024 Nov; 90(11):2921-2929.

View in: PubMed
Cappuccio JM, Mehta N, Pellish R. Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade?) versus Biosimilar Infliximab (Renflexis?) for Acute Severe Ulcerative Colitis. Dig Dis. 2024; 42(5):496-502.

View in: PubMed
Canales-Herrerias P, Uzzan M, Seki A, Czepielewski RS, Verstockt B, Livanos AE, Raso F, Dunn A, Dai D, Wang A, Al-Taie Z, Martin J, Laurent T, Ko HM, Tokuyama M, Tankelevich M, Meringer H, Cossarini F, Jha D, Krek A, Paulsen JD, Taylor MD, Nakadar MZ, Wong J, Erlich EC, Mintz RL, Onufer EJ, Helmink BA, Sharma K, Rosenstein A, Ganjian D, Chung G, Dawson T, Juarez J, Yajnik V, Cerutti A, Faith JJ, Suarez-Farinas M, Argmann C, Petralia F, Randolph GJ, Polydorides AD, Reboldi A, Colombel JF, Mehandru S. Gut-associated lymphoid tissue attrition associates with response to anti-a4?7 therapy in ulcerative colitis. Sci Immunol. 2024 04 19; 9(94):eadg7549.

View in: PubMed
Kim C, Brown FL, Burk C, Anatchkova M, Sargalo N, Kaushik A. Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures. Qual Life Res. 2024 May; 33(5):1373-1387.

View in: PubMed
Johnson JL, Sargsyan D, Neiman EM, Hart A, Stojmirovic A, Kosoy R, Irizar H, Su?rez-Fari?as M, Song WM, Argmann C, Avey S, Shmuel-Galia L, Vierbuchen T, Bongers G, Sun Y, Edelstein L, Perrigoue J, Towne JE, Hall AO, Fitzgerald KA, Hoebe K. Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease. JCI Insight. 2024 Feb 08; 9(3).

View in: PubMed

People

Explore

Similar Concepts

Top Journals